These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3835576)

  • 1. [Determination of the antiplasmin activity of platelets with a chromogenic substrate].
    Campo G; Ciaffoni S
    Quad Sclavo Diagn; 1985 Sep; 21(3):360-9. PubMed ID: 3835576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of kallikrein in gel-filtered urine using the chromogenic substrate D-valyl-L-leucyl-L-arginyl-4-nitroanilide].
    Jung K; Klotzek S
    Z Med Lab Diagn; 1991; 32(2):116-7. PubMed ID: 2068862
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of inhibitors with chromogenic substrates.
    Latallo ZS
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():48-9. PubMed ID: 6159376
    [No Abstract]   [Full Text] [Related]  

  • 4. Modification of the immediate plasmin inhibition assay to secure linearity of the reference curve with the chromogenic substrate S-2251.
    Jespersen J; Gram J; Sidelmann J
    Thromb Haemost; 1984 Apr; 51(2):298. PubMed ID: 6740562
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of chromogenic substrate S-2251 for determination of plasminogen activator in rat ovaries.
    Shimada H; Mori T; Takada A; Takada Y; Noda Y; Takai I; Kohda H; Nishimura T
    Thromb Haemost; 1981 Aug; 46(2):507-10. PubMed ID: 7197812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic peculiarities of human tissue kallikrein: 1--substrate activation in the catalyzed hydrolysis of H-D-valyl-L-leucyl-L-arginine 4-nitroanilide and H-D-valyl-L-leucyl-L-lysine 4-nitroanilide; 2--substrate inhibition in the catalyzed hydrolysis of N alpha-p-tosyl-L-arginine methyl ester.
    Sousa MO; Miranda TL; Maia CN; Bittar ER; Santoro MM; Figueiredo AF
    Arch Biochem Biophys; 2002 Apr; 400(1):7-14. PubMed ID: 11913965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation].
    Vogel G; Stürzebecher J; Klessen C; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of increased thrombotic tendency with chromogenic substrates].
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):135-41. PubMed ID: 6177594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluations of antithrombin III and alpha 2-plasmin inhibitor assay method with chromogenic substrates (S-2238, S-2251 (author's transl)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1981 Feb; 29(2):179-82. PubMed ID: 6453246
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional activities and concentrations of plasmin inhibitors in normal subjects and D.I.C. patients.
    Velasco F; Torres A; Andres P; Duran MI
    Thromb Haemost; 1982 Jun; 47(3):275-7. PubMed ID: 6180498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The determination of inhibitors of haemostasis using chromogenic substances (author's transl)].
    Jürgens H; von Voss H; Göbel U
    Klin Padiatr; 1980 Jul; 192(4):330-5. PubMed ID: 7192767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on tissue thromboplastic activity assay method with chromogenic substrates (S-2222)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1984 Mar; 32(3):313-6. PubMed ID: 6737742
    [No Abstract]   [Full Text] [Related]  

  • 13. [alpha 2-Macroglobulin in serum and plasma: reference values with carbobenzoxy-valyl-glycyl-arginine-p-nitroanilide, a chromogenic substrate].
    Witt I; Tritschler W
    J Clin Chem Clin Biochem; 1983 Jul; 21(7):429-36. PubMed ID: 6194247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revised reference curve for the alpha 2-antiplasmin assay by the addition of detergents.
    Kluft C; Wijngaards G; van Voorthuizen H
    Thromb Haemost; 1984 Apr; 51(2):297. PubMed ID: 6740561
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of human and ovine acrosomal enzymes by tannic acid in vitro.
    Taitzoglou IA; Tsantarliotou M; Zervos I; Kouretas D; Kokolis NA
    Reproduction; 2001 Jan; 121(1):131-7. PubMed ID: 11226036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of a new fibrinolysis inhibitor by chromogenic substrates: the fast antiplasmin (author's transl)].
    Diaz-Cremades JM; Vicente JM; Borrell M; Felez J; Gimferrer E; Pujol N; Domingo A; Rutllant ML
    Sangre (Barc); 1978; 23(3):347-57. PubMed ID: 675457
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on plasma prekallikrein assay method with chromogenic substrates (S-2302)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1983 Feb; 31(2):219-22. PubMed ID: 6190027
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement of fibrinolytic activity of human plasma in the presence of acetone.
    Adamus K; Pajdak W
    Scand J Clin Lab Invest; 1994 Aug; 54(5):353-9. PubMed ID: 7997840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The determination of blood fibrinolytic activity by synthetic chromogenic substrate S-2251 in patients with high risk of thromboembolism.
    Mijović A; Rolović Z
    Acta Med Iugosl; 1978; 32(5):429-39. PubMed ID: 742406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.